Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Plx Q4 Earnings Misses Estimates By 0.08 20260403 Is Webster Wbs Stock Moving Sideways Wbs Q4 Earnings Beats Estimates By 0.04 20260408 1 Will Bumble Bmbl Stock Hit Record Highs Price At 3.39 Up 0.89 20260406 Is Realloys Aloy Stock Slowing Down Price At 7.84 Down 9.78 20260408 Agios Pharmaceuticals AGIO Q1 2026 Earnings Beat and Mitapivat Pipeline Update Drive 13 SingleDay Rally The working capital efficiency at Flexible FSI Flexible posts surprise loss misses EPS estimates by 1594 LOKVW Live Oak outlines new potential merger targets as quarterly earnings metrics remain undisclosed Intercontinental Exchange ICE Q1 2026 Earnings Beat Driven by Record Revenue Growth and Strategic Moat Expansion New York Times Pips Puzzle Subscriber Engagement Trends in Digital Word Games Manchesters Defining Spirit of Collectivism and Entrepreneurialism May Influence UK National Policy April Jobs Report Preview Labor Market Cooling But Remains Resilient Indian StateRun Oil Stocks Surge Up to 6 as Crude Falls and Fuel Prices Rise CoreWeave Stock Cautious Outlook Amid AI Infrastructure Boom China Investors Shift to Overseas Brokers Amid Crackdown on Illicit Stock Trading Mesa Laboratories Inc MLAB Q1 2026 Earnings Strong EPS Surprise of 130 Amid Quiet Revenue Disclosure TNET Q1 2026 Earnings EPS Surges Past Expectations with 32 Beat RBB Q1 2026 Earnings Strong EPS Beat Exceeds Estimates SION Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Advances Pipeline ACLS Q1 2026 Earnings EPS Misses Estimate Marginally Stock Rises 29 FSEA Q3 2024 Earnings Positive EPS of 001 Marks Operational Stability Prosperity Bancshares PB Slips 133 as Support Test Looms Sector Headwinds Persist West Fraser Timber Edges Higher as Support Holds Resistance in Focus Riverview Bancorp RVSB Creeps Higher as Buyers Defend Key Support Microvast Holdings MVST Shows Resilience Climbing 58 to 146 Atea Pharmaceuticals AVIR Gains 425 as Stock Tests Key Resistance Level